Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
2.
Curr Opin Infect Dis ; 33(4): 304-311, 2020 08.
Artículo en Inglés | MEDLINE | ID: covidwho-643197

RESUMEN

PURPOSE OF THE REVIEW: Laboratory-developed tests (LDTs) are essential for the clinical care of immunocompromised individuals. These patients often require specialized testing not available from commercial manufacturers and are therefore dependent on the laboratory to create, validate, and perform these assays. Recent paradigm-shifting legislation could alter the way that LDTs are operationalized and regulated. RECENT FINDINGS: On March 5th, 2020 the Verifying Accurate and Leading-Edge In-Vitro Clinical Tests Development Act (VALID) was introduced in the US Congress. This statute would overhaul existing regulatory framework by unifying the oversight of LDTs and commercial in-vitro diagnostic tests (IVDs) through the FDA. If enacted, LDTs would be subject to regulatory requirements like those found in commercial submissions for market review. Stakeholders continue to discuss the details and scope of the proposed legislation in the setting of the Severe Acute Respiratory Syndrome Coronavirus 2 pandemic, where LDTs are integral to the national COVID-19 response. SUMMARY: Congressional lawmakers have introduced legislation to alter the regulatory framework governing LDTs. Moving forward, a balance must be struck to ensure the availability of safe and accurate testing without delays or overregulation that could be harmful to patients. The downstream implications of how VALID and other legislation will impact laboratories, clinicians, and patients warrant close examination.


Asunto(s)
Servicios de Laboratorio Clínico/legislación & jurisprudencia , Técnicas de Laboratorio Clínico , Infecciones por Coronavirus/diagnóstico , Huésped Inmunocomprometido , Laboratorios de Hospital/legislación & jurisprudencia , Neumonía Viral/diagnóstico , Incertidumbre , United States Food and Drug Administration/legislación & jurisprudencia , Betacoronavirus/patogenicidad , Congresos como Asunto , Investigación sobre Servicios de Salud/legislación & jurisprudencia , Humanos , Pandemias , Garantía de la Calidad de Atención de Salud , Estados Unidos
4.
mSphere ; 5(4)2020 07 08.
Artículo en Inglés | MEDLINE | ID: covidwho-639765

RESUMEN

Nipah disease is listed as one of the WHO priority diseases that pose the greatest public health risk due to their epidemic potential. More than 200 experts from around the world convened in Singapore last year to mark the 20th anniversary of the first Nipah virus outbreaks in Malaysia and Singapore. Most of these experts are now involved in responding to the coronavirus disease 2019 (COVID-19) pandemic. Here, members of the Organizing Committee of the 2019 Nipah Virus International Conference review highlights from the Nipah@20 Conference and reflect on key lessons learned from Nipah that could be applied to the understanding of the COVID-19 pandemic and to preparedness against future emerging infectious diseases (EIDs) of pandemic potential.


Asunto(s)
Infecciones por Henipavirus , Virus Nipah/patogenicidad , Animales , Betacoronavirus/patogenicidad , Congresos como Asunto , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/terapia , Infecciones por Henipavirus/diagnóstico , Infecciones por Henipavirus/prevención & control , Infecciones por Henipavirus/terapia , Humanos , Pandemias/prevención & control , Neumonía Viral/diagnóstico , Neumonía Viral/prevención & control , Neumonía Viral/terapia , Zoonosis/epidemiología
8.
East Mediterr Health J ; 26(5): 492-494, 2020 May 21.
Artículo en Inglés | MEDLINE | ID: covidwho-600973

RESUMEN

The coronavirus disease 2019 (COVID-19) outbreak that began in Wuhan, Hubei Province, China in late 2019 has spread globally within a few months. The Director General of the World Health Organization (WHO) declared the COVID-19 outbreak to be a public health emergency of international concern (PHEIC) after the second meeting of the IHR (2005) Emergency Committee on 30 January 2020. On 12 March 2020, the outbreak of COVID-19 was characterized as a pandemic.


Asunto(s)
Control de Enfermedades Transmisibles/métodos , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/prevención & control , Betacoronavirus , Ensayos Clínicos como Asunto , Control de Enfermedades Transmisibles/economía , Congresos como Asunto , Brotes de Enfermedades , Financiación Gubernamental , Humanos , Región Mediterránea/epidemiología , Pandemias , Neumonía Viral , Organización Mundial de la Salud
11.
J Cancer Res Ther ; 16(2): 350-355, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-455553

RESUMEN

The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and their critical morbidity and case fatality rates are high. The ablation expert committee of the Chinese Society of Clinical Oncology compiled corresponding expert recommendations. These recommendations summarize the preventive measures and management of tumor ablation treatment in medical institutions, including outpatient clinics, oncology wards, ablation operation room, and postablation follow-ups in accordance with the guidelines and protocols imposed by the National Health Commission of the People's Republic of China and the experience in management and prevention according to various hospitals. This consensus aims to reduce and prevent the spread of SARS-CoV-2 and its cross-infection between cancer patients in hospitals and provide regulatory advice and guidelines for medical personnel.


Asunto(s)
Betacoronavirus , Ablación por Catéter/efectos adversos , Infecciones Relacionadas con Catéteres/prevención & control , Infecciones por Coronavirus/prevención & control , Brotes de Enfermedades , Neoplasias/cirugía , Pandemias/prevención & control , Neumonía Viral/prevención & control , Guías de Práctica Clínica como Asunto/normas , Infecciones Relacionadas con Catéteres/virología , China/epidemiología , Congresos como Asunto , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Humanos , Neoplasias/patología , Neoplasias/virología , Neumonía Viral/complicaciones , Neumonía Viral/epidemiología , Neumonía Viral/virología
12.
J Cosmet Dermatol ; 19(8): 1822-1825, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: covidwho-618392

RESUMEN

BACKGROUND: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; COVID-19), which causes coronavirus disease 2019, is highly contagious and a particularly popular problem in all around the world and also in all departments of every hospital. AIMS: Protecting the well-being of the aesthetic dermatologists while providing a sufficient workforce is vital for pandemic planning. RESULTS AND CONCLUSIONS: In this article, we will discuss this problem from an aesthetic dermatology aspect and we will review whether these procedures are safe or not.


Asunto(s)
Betacoronavirus/patogenicidad , Infecciones por Coronavirus/prevención & control , Técnicas Cosméticas , Dermatología/organización & administración , Control de Infecciones/organización & administración , Pandemias/prevención & control , Neumonía Viral/prevención & control , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/normas , Congresos como Asunto/normas , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Infecciones por Coronavirus/virología , Dermatólogos/organización & administración , Dermatólogos/normas , Dermatología/educación , Dermatología/normas , Educación Médica/organización & administración , Educación Médica/normas , Estética , Higiene de las Manos/normas , Humanos , Control de Infecciones/instrumentación , Control de Infecciones/normas , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Transmisión de Enfermedad Infecciosa de Profesional a Paciente/prevención & control , Equipo de Protección Personal/normas , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Neumonía Viral/virología , Telemedicina/organización & administración , Telemedicina/normas
13.
Head Neck ; 42(7): 1526-1532, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: covidwho-434497

RESUMEN

The COVID-19 pandemic has had a significant impact on many aspects of head and neck cancer (HNC) care. The uncertainty and stress resulting from these changes has led many patients and caregivers to turn to HNC advocacy groups for guidance and support. Here we outline some of the issues being faced by patients with HNC during the current crisis and provide examples of programs being developed by advocacy groups to address them. We also highlight the increased utilization of these organizations that has been observed as well as some of the challenges being faced by these not-for-profit groups as they work to serve the head and neck community.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/epidemiología , Fundaciones , Neoplasias de Cabeza y Cuello , Organizaciones sin Fines de Lucro , Neumonía Viral/epidemiología , Congresos como Asunto , Humanos , Pandemias , Defensa del Paciente , Educación del Paciente como Asunto , Medios de Comunicación Sociales , Telemedicina
14.
J Cosmet Dermatol ; 19(8): 1822-1825, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: covidwho-382155

RESUMEN

BACKGROUND: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; COVID-19), which causes coronavirus disease 2019, is highly contagious and a particularly popular problem in all around the world and also in all departments of every hospital. AIMS: Protecting the well-being of the aesthetic dermatologists while providing a sufficient workforce is vital for pandemic planning. RESULTS AND CONCLUSIONS: In this article, we will discuss this problem from an aesthetic dermatology aspect and we will review whether these procedures are safe or not.


Asunto(s)
Betacoronavirus/patogenicidad , Infecciones por Coronavirus/prevención & control , Técnicas Cosméticas , Dermatología/organización & administración , Control de Infecciones/organización & administración , Pandemias/prevención & control , Neumonía Viral/prevención & control , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/normas , Congresos como Asunto/normas , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Infecciones por Coronavirus/virología , Dermatólogos/organización & administración , Dermatólogos/normas , Dermatología/educación , Dermatología/normas , Educación Médica/organización & administración , Educación Médica/normas , Estética , Higiene de las Manos/normas , Humanos , Control de Infecciones/instrumentación , Control de Infecciones/normas , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Transmisión de Enfermedad Infecciosa de Profesional a Paciente/prevención & control , Equipo de Protección Personal/normas , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Neumonía Viral/virología , Telemedicina/organización & administración , Telemedicina/normas
17.
Cell Syst ; 10(5): 379-380, 2020 05 20.
Artículo en Inglés | MEDLINE | ID: covidwho-324678

RESUMEN

We asked speakers from the Annual International Conference on Research in Computational Molecular Biology (RECOMB) about how computational biology as a discipline is being affected by COVID-19 and how the expertise of their community can help in the global response to the pandemic.


Asunto(s)
Biología Computacional/métodos , Congresos como Asunto , Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Humanos , Comunicación Interdisciplinaria , Pandemias , Programas Informáticos
19.
Emerg Infect Dis ; 26(8): 1935-1937, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: covidwho-240299

RESUMEN

During a meeting in Munich, Germany, a presymptomatic attendee with severe acute respiratory syndrome coronavirus 2 infected at least 11 of 13 other participants. Although 5 participants had no or mild symptoms, 6 had typical coronavirus disease, without dyspnea. Our findings suggest hand shaking and face-to-face contact as possible modes of transmission.


Asunto(s)
Betacoronavirus/patogenicidad , Trazado de Contacto/estadística & datos numéricos , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Brotes de Enfermedades , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Adulto , Enfermedades Asintomáticas , Betacoronavirus/fisiología , Técnicas de Laboratorio Clínico/métodos , Congresos como Asunto , Infecciones por Coronavirus/diagnóstico , Alemania/epidemiología , Humanos , Persona de Mediana Edad , Pandemias , Neumonía Viral/diagnóstico , Índice de Severidad de la Enfermedad , Tomografía Computarizada por Rayos X
20.
Neurology ; 94(24): e2608-e2614, 2020 06 16.
Artículo en Inglés | MEDLINE | ID: covidwho-209998

RESUMEN

OBJECTIVE: To outline changes made to a neurology residency program in response to coronavirus disease 2019 (COVID-19). METHODS: In early March 2020, the first cases of COVID-19 were announced in the United States. New York City quickly became the epicenter of a global pandemic, and our training program needed to rapidly adapt to the increasing number of inpatient cases while being mindful of protecting providers and continuing education. Many of these changes unfolded over days, including removing residents from outpatient services, minimizing the number of residents on inpatient services, deploying residents to medicine services and medical intensive care units, converting continuity clinic patient visits to virtual options, transforming didactics to online platforms only, and maintaining connectedness in an era of social distancing. We have been able to accomplish this through daily virtual meetings among leadership, faculty, and residents. RESULTS: Over time, our program has successfully rolled out initiatives to service the growing number of COVID-related inpatients while maintaining neurologic care for those in need and continuing our neurologic education curriculum. CONCLUSION: It has been necessary and feasible for our residency training program to undergo rapid structural changes to adapt to a medical crisis. The key ingredients in doing this successfully have been flexibility and teamwork. We suspect that many of the implemented changes will persist long after the COVID-19 crisis has passed and will change the approach to neurologic and medical training.


Asunto(s)
Infecciones por Coronavirus , Educación de Postgrado en Medicina/organización & administración , Neurología/educación , Pandemias , Neumonía Viral , Centros Médicos Académicos , Atención Ambulatoria , Betacoronavirus , Congresos como Asunto , Educación a Distancia , Electroencefalografía/instrumentación , Electroencefalografía/métodos , Servicio de Urgencia en Hospital , Recursos en Salud , Humanos , Unidades de Cuidados Intensivos , Ciudad de Nueva York , Equipo de Protección Personal , Derivación y Consulta , Telemedicina , Comunicación por Videocoferencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA